1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Endometrial Cancer-Pipeline Insights, 2016

Endometrial Cancer-Pipeline Insights, 2016

  • November 2016
  • -
  • Delve Insight
  • -
  • 60 pages


DelveInsight’s, “ Endometrial Cancer-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Endometrial Cancer. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Endometrial Cancer. DelveInsight’s Report also assesses the Endometrial Cancer therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitivepipeline landscape of Endometrial Cancer
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Endometrial Cancer pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Endometrial Cancer and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Endometrial Cancer-Pipeline Insights, 2016

Illustrative Table of contents

- Endometrial Cancer Overview
- Endometrial Cancer Pipeline Therapeutics
- Endometrial Cancer Therapeutics under Development by Companies
- Endometrial Cancer Filed and Phase III Products
- Comparative Analysis
- Endometrial Cancer Phase II Products
- Comparative Analysis
- Endometrial Cancer Phase I and IND Filed Products
- Comparative Analysis
- Endometrial Cancer Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Endometrial Cancer - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Endometrial Cancer - Discontinued Products
- Endometrial Cancer - Dormant Products
- Companies Involved in Therapeutics Development for Endometrial Cancer
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Endometrial Cancer, 2016
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2016
- Comparative Analysis Phase II Products, 2016
- Comparative Analysis Phase I and IND Filed Products, 2016
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
- Drug Candidates Profiles
- Endometrial Cancer Assessment by Monotherapy Products
- Endometrial Cancer Assessment by Combination Products
- Endometrial Cancer Assessment by Route of Administration
- Endometrial Cancer Assessment by Stage and Route of Administration
- Endometrial Cancer Assessment by Molecule Type
- Endometrial Cancer Assessment by Stage and Molecule Type
- Endometrial Cancer Therapeutics - Discontinued Products
- Endometrial Cancer Therapeutics - Dormant Products
- Products under Development by Companies, 2016

List of Figures

- Number of Products under Development for Endometrial Cancer, 2016
- Filed and Phase III Products, 2016
- Phase II Products, 2016
- Phase I and IND Filed Products, 2016
- Discovery and Pre-Clinical Stage Products, 2016
- Endometrial Cancer Assessment by Monotherapy Products
- Endometrial Cancer Assessment by Combination Products
- Endometrial Cancer Assessment by Route of Administration
- Endometrial Cancer Assessment by Stage and Route of Administration
- Endometrial Cancer Assessment by Molecule Type
- Endometrial Cancer Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Endometrial Cancer - Market Insights, Epidemiology and Market Forecast-2023

Endometrial Cancer - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Endometrial Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and ...

Global Endometrial Cancer Market - Growth, Trends and Forecasts (2016 - 2021)

Global Endometrial Cancer Market - Growth, Trends and Forecasts (2016 - 2021)

  • $ 4250
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The global endometrial cancer market is expected to grow at a CAGR of XX% during the forecast period 2016-2021. The market was valued at USD XX million in 2015 and is forecasted to reach USD XX million ...

Endometrial Cancer - Epidemiology Forecast To 2023

Endometrial Cancer - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight “Endometrial Cancer - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Endometrial Cancer in seven major markets (US, France, Germany, Italy, Spain, UK ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the UK

  • November 2016
    20 pages
  • Cancer  

    Blood Transfusi...  

  • United Kingdom  

    United States  

View report >

Colorectal Cancer Statistics in the Netherlands

  • November 2016
    10 pages
  • Colorectal Canc...  

  • Netherlands  

View report >

Obesity Statistics and Cancer Statistics in the US

  • November 2016
    7 pages
  • Obesity  

    Cancer  

    Oncology  

  • United States  

    North America  

View report >

Related Market Segments :

Endometrial Cancer

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.